{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T01:03:32Z","timestamp":1794013412565,"version":"4.8.0"},"reference-count":147,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.fertnstert.2024.01.018","type":"journal-article","created":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T12:28:47Z","timestamp":1705580927000},"page":"384-399","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"title":["Management of polycystic ovary syndrome must include assessment and treatment of mental health symptoms"],"prefix":"10.1016","volume":"121","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2445-4571","authenticated-orcid":false,"given":"Snigdha","family":"Alur-Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anuja","family":"Dokras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2374-3806","authenticated-orcid":false,"given":"Laura G.","family":"Cooney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2024.01.018_bib1","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1093\/humrep\/dew218","article-title":"The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis","volume":"31","author":"Bozdag","year":"2016","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib2","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/j.fertnstert.2016.07.1121","article-title":"Phenotypes and body mass in women with polycystic ovary syndrome identified in referral versus unselected populations: systematic review and meta-analysis","volume":"106","author":"Lizneva","year":"2016","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib3","doi-asserted-by":"crossref","first-page":"e157","DOI":"10.1097\/AOG.0000000000002656","article-title":"ACOG Practice Bulletin No. 194: Polycystic ovary syndrome","volume":"131","year":"2018","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib4","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.fertnstert.2018.01.038","article-title":"Androgen Excess- polycystic ovary syndrome Society: position statement on depression, anxiety, quality of life, and eating disorders in polycystic ovary syndrome","volume":"109","author":"Dokras","year":"2018","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib5","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.fertnstert.2018.05.004","article-title":"Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"110","author":"Teede","year":"2018","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib6","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1080\/09513590.2020.1746761","article-title":"Knowledge of PCOS in physicians-in-training: identifying gaps and educational opportunities","volume":"36","author":"Chemerinski","year":"2020","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib7","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.fertnstert.2017.04.011","article-title":"Gaps in knowledge among physicians regarding diagnostic criteria and management of polycystic ovary syndrome","volume":"107","author":"Dokras","year":"2017","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib8","first-page":"604","article-title":"Delayed diagnosis and a lack of information associated with dissatisfaction in women with polycystic ovary syndrome","volume":"102","author":"Gibson-Helm","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib9","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1001\/archinte.160.14.2101","article-title":"Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence","volume":"160","author":"DiMatteo","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph182413268","article-title":"Adherence to lifestyle interventions for treatment of adults with depression: a systematic review and meta-analysis","volume":"18","author":"Castro","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib11","doi-asserted-by":"crossref","first-page":"492","DOI":"10.3390\/nu11030492","article-title":"Predictors of lifestyle intervention attrition or weight loss success in women with polycystic ovary syndrome who are overweight or obese","volume":"11","author":"Moran","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib12","series-title":"Technical report for the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome","author":"Mousa","year":"2023"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib13","series-title":"Depression and other common mental disorders: global health estimates","year":"2017"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib14","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1001\/jama.2015.18392","article-title":"Screening for depression in adults: US Preventive Services Task Force recommendation statement","volume":"315","author":"Siu","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib15","series-title":"text revision","article-title":"Diagnostic and statistical manual of mental disorders: DSM-5-TR","year":"2022"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib16","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1093\/humrep\/dex044","article-title":"High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: a systematic review and meta-analysis","volume":"32","author":"Cooney","year":"2017","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib17","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1515\/ijamh-2022-0065","article-title":"Depression and anxiety in adolescents and young women with polycystic ovary syndrome: a systematic review and meta-analysis","volume":"35","author":"Nasiri-Amiri","year":"2023","journal-title":"Int J Adolesc Med Health"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib18","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1080\/09513590.2021.1942452","article-title":"The prevalence of anxiety and depression of different severity in women with polycystic ovary syndrome: a meta-analysis","volume":"37","author":"Wang","year":"2021","journal-title":"Gynecol Endocrinol"},{"issue":"4","key":"10.1016\/j.fertnstert.2024.01.018_bib19","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.fertnstert.2023.07.025","article-title":"Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"120","author":"Teede","year":"2023","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib20","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1210\/jc.2016-3863","article-title":"Psychological distress is more prevalent in fertile age and premenopausal women with PCOS symptoms: 15-year follow-up","volume":"102","author":"Karjula","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib21","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1210\/jc.2019-00234","article-title":"Depression over the lifespan in a population-based cohort of women with polycystic ovary syndrome: longitudinal analysis","volume":"104","author":"Greenwood","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib22","doi-asserted-by":"crossref","first-page":"E868","DOI":"10.1210\/jc.2011-3357","article-title":"Relative contributions of oligomenorrhea and hyperandrogenemia to the risk of metabolic syndrome in midlife women","volume":"97","author":"Polotsky","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib23","first-page":"230","article-title":"Racial differences in anxiety, depression, and quality of life in women with polycystic ovary syndrome","volume":"2","author":"Alur-Gupta","year":"2021","journal-title":"F S Rep"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib24","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1111\/1471-0528.17428","article-title":"Emotional and psychosexual well-being is influenced by ethnicity and birthplace in women and individuals with polycystic ovary syndrome in the UK and India","volume":"130","author":"Sheikh","year":"2023","journal-title":"BJOG"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib25","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1530\/EC-14-0010","article-title":"Effect of lifestyle intervention on the reproductive endocrine profile in women with polycystic ovarian syndrome: a systematic review and meta-analysis","volume":"3","author":"Haqq","year":"2014","journal-title":"Endocr Connect"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib26","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007506.pub3","article-title":"Lifestyle changes in women with polycystic ovary syndrome","author":"Moran","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib27","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1186\/s12889-021-12280-9","article-title":"Effectiveness of exercise interventions on mental health and health-related quality of life in women with polycystic ovary syndrome: a systematic review","volume":"21","author":"Patten","year":"2021","journal-title":"BMC Public Health"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib28","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.jad.2019.11.025","article-title":"The effects of aerobic physical exercises on body image among women with polycystic ovary syndrome","volume":"262","author":"Kogure","year":"2020","journal-title":"J Affect Disord"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib29","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1111\/jsm.12909","article-title":"Impact of physical resistance training on the sexual function of women with polycystic ovary syndrome","volume":"12","author":"Lara","year":"2015","journal-title":"J Sex Med"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib30","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1016\/j.fertnstert.2009.11.001","article-title":"Lifestyle management improves quality of life and depression in overweight and obese women with polycystic ovary syndrome","volume":"94","author":"Thomson","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib31","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13102-016-0039-8","article-title":"The feasibility of progressive resistance training in women with polycystic ovary syndrome: a pilot randomized controlled trial","volume":"8","author":"Vizza","year":"2016","journal-title":"BMC Sports Sci Med Rehabil"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib32","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s11920-017-0834-2","article-title":"Depression and anxiety in polycystic ovary syndrome: etiology and treatment","volume":"19","author":"Cooney","year":"2017","journal-title":"Curr Psychiatry Rep"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib33","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1038\/s41598-023-29503-1","article-title":"Efficacy of high-intensity interval training for improving mental health and health-related quality of life in women with polycystic ovary syndrome","volume":"13","author":"Patten","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2022.948414","article-title":"Effects of high-intensity interval training in combination with detraining on mental health in women with polycystic ovary syndrome: a randomized controlled trial","volume":"13","author":"Santos","year":"2022","journal-title":"Front Physiol"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib35","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.appet.2007.03.222","article-title":"Psychological benefits of a high-protein, low-carbohydrate diet in obese women with polycystic ovary syndrome-a pilot study","volume":"49","author":"Galletly","year":"2007","journal-title":"Appetite"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib36","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.sapharm.2019.08.027","article-title":"Prevalence of anxiety and depression among women with polycystic ovary syndrome living in war versus non-war zone countries: a randomized controlled trial assessing a pharmacist intervention","volume":"16","author":"Alkoudsi","year":"2020","journal-title":"Res Social Adm Pharm"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib37","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jagp.2023.08.010","article-title":"The antidepressant effects of GLP-1 receptor agonists: a systematic review and meta-analysis","volume":"32","author":"Chen","year":"2024","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib38","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1080\/09513590.2018.1505848","article-title":"The effects of treatment with liraglutide on quality of life and depression in young obese women with PCOS and controls","volume":"35","author":"Kahal","year":"2019","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib39","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1210\/jc.2016-1896","article-title":"Weight loss and lowering androgens predict improvements in health-related quality of life in women with PCOS","volume":"101","author":"Dokras","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib40","doi-asserted-by":"crossref","first-page":"e110","DOI":"10.1192\/bjo.2021.64","article-title":"Hormonal contraceptive use and depressive symptoms: systematic review and network meta-analysis of randomised trials","volume":"7","author":"de Wit","year":"2021","journal-title":"BJPsych Open"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib41","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1093\/humrep\/des113","article-title":"Effect of an oral contraceptive on emotional distress, anxiety and depression of women with polycystic ovary syndrome: a prospective study","volume":"27","author":"Cinar","year":"2012","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib42","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.fertnstert.2018.03.009","article-title":"Insulin resistance is associated with depression risk in polycystic ovary syndrome","volume":"110","author":"Greenwood","year":"2018","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib43","doi-asserted-by":"crossref","first-page":"737","DOI":"10.2147\/PPA.S244273","article-title":"Metformin improves the depression symptoms of women with polycystic ovary syndrome in a lifestyle modification program","volume":"14","author":"AlHussain","year":"2020","journal-title":"Patient Prefer Adherence"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib44","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1080\/09513590.2018.1498476","article-title":"A pilot trial of metformin for insulin resistance and mood disturbances in adolescent and adult women with polycystic ovary syndrome","volume":"35","author":"Erensoy","year":"2019","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib45","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.3390\/metabo12121183","article-title":"Myoinositol vs. metformin in Women with polycystic ovary syndrome: a randomized controlled clinical trial","volume":"12","author":"Ravn","year":"2022","journal-title":"Metabolites"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib46","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2147\/NDT.S121149","article-title":"Pioglitazone could induce remission in major depression: a meta-analysis","volume":"13","author":"Colle","year":"2017","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib47","first-page":"49","article-title":"PPAR-\u03b3 agonists for the treatment of major depression: a review","volume":"50","author":"Colle","year":"2017","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib48","doi-asserted-by":"crossref","first-page":"732","DOI":"10.2174\/1570159X14666151208113700","article-title":"Inflammation in depression and the potential for anti-inflammatory treatment","volume":"14","author":"Kohler","year":"2016","journal-title":"Curr Neuropharmacol"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib49","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/bdi.12373","article-title":"Anti-inflammatory agents in the treatment of bipolar depression: a systematic review and meta-analysis","volume":"18","author":"Rosenblat","year":"2016","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib50","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.psyneuen.2012.08.010","article-title":"Does pioglitazone improve depression through insulin-sensitization? Results of a randomized double-blind metformin-controlled trial in patients with polycystic ovarian syndrome and comorbid depression","volume":"38","author":"Kashani","year":"2013","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib51","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/3050487","article-title":"Pioglitazone metformin complex improves polycystic ovary syndrome comorbid psychological distress via inhibiting NLRP3 inflammasome activation: A prospective clinical study","volume":"2020","author":"Guo","year":"2020","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib52","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.2147\/NDT.S385014","article-title":"Changes in mood, anxiety, and cognition with polycystic ovary syndrome treatment: a longitudinal, naturalistic study","volume":"18","author":"Sukhapure","year":"2022","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib53","first-page":"1","article-title":"Practice guideline for the treatment of patients with major depressive disorder (revision)","volume":"157","year":"2000","journal-title":"American Psychiatric Association. Am J Psychiatry"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib54","unstructured":"National Institute for Health and Care Excellence [guidelines]. Depression in adults: treatment and management. In: London: National Institute for Health and Care Excellence (NICE)."},{"key":"10.1016\/j.fertnstert.2024.01.018_bib55","doi-asserted-by":"crossref","first-page":"350","DOI":"10.7326\/M15-2570","article-title":"Clinical Guidelines Committee of the American College of Physicians. Nonpharmacologic versus pharmacologic treatment of adult patients with major depressive disorder: a clinical practice guideline from the American College of Physicians","volume":"164","author":"Qaseem","year":"2016","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib56","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/wps.20346","article-title":"How effective are cognitive behavior therapies for major depression and anxiety disorders? A meta-analytic update of the evidence","volume":"15","author":"Cuijpers","year":"2016","journal-title":"World Psychiatry"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib57","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.rbmo.2022.05.001","article-title":"Cognitive behavioural therapy for depression in women with PCOS: systematic review and meta-analysis","volume":"45","author":"Jiskoot","year":"2022","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib58","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyg.2022.796594","article-title":"The effects of cognitive behavioral therapy in women with polycystic ovary syndrome: a meta-analysis","volume":"13","author":"Tang","year":"2022","journal-title":"Front Psychol"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib59","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/YIC.0000000000000367","article-title":"Effect of sertraline on depression severity and prolactin levels in women with polycystic ovary syndrome: a placebo-controlled randomized trial","volume":"36","author":"Masoudi","year":"2021","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib60","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1001\/jamapsychiatry.2017.0056","article-title":"Cross-sectional comparison of the epidemiology of DSM-5 generalized anxiety disorder across the globe","volume":"74","author":"Ruscio","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib61","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/mpr.1359","article-title":"Twelve-month and lifetime prevalence and lifetime morbid risk of anxiety and mood disorders in the United States","volume":"21","author":"Kessler","year":"2012","journal-title":"Int J Methods Psychiatr Res"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib62","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.fertnstert.2019.06.018","article-title":"Body-image distress is increased in women with polycystic ovary syndrome and mediates depression and anxiety","volume":"112","author":"Alur-Gupta","year":"2019","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib63","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jad.2019.05.006","article-title":"Body image and its relationships with sexual functioning, anxiety, and depression in women with polycystic ovary syndrome","volume":"253","author":"Kogure","year":"2019","journal-title":"J Affect Disord"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib64","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.comppsych.2018.12.008","article-title":"Racial\/ethnic differences in 12-month prevalence and persistence of mood, anxiety, and substance use disorders: variation by nativity and socioeconomic status","volume":"89","author":"Vilsaint","year":"2019","journal-title":"Compr Psychiatry"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib65","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/1472-6882-13-131","article-title":"Acupuncture and physical exercise for affective symptoms and health-related quality of life in polycystic ovary syndrome: secondary analysis from a randomized controlled trial","volume":"13","author":"Stener-Victorin","year":"2013","journal-title":"BMC Complement Altern Med"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib66","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/09513590.2021.1991910","article-title":"The effects of coenzyme Q10 supplementation on metabolic profiles and parameters of mental health in women with polycystic ovary syndrome","volume":"38","author":"Karamali","year":"2022","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib67","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/13625187.2017.1422239","article-title":"Ongoing or previous mental disorders predispose to adverse mood reporting during combined oral contraceptive use","volume":"23","author":"Bengtsdotter","year":"2018","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib68","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jpsychires.2019.09.016","article-title":"No pills, more skills: the adverse effect of hormonal contraceptive use on exposure therapy benefit","volume":"119","author":"Raeder","year":"2019","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib69","doi-asserted-by":"crossref","first-page":"5935","DOI":"10.1523\/JNEUROSCI.2904-18.2019","article-title":"Metformin promotes anxiolytic and antidepressant-like responses in insulin-resistant mice by decreasing circulating branched-chain amino acids","volume":"39","author":"Zemdegs","year":"2019","journal-title":"J Neurosci"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib70","article-title":"Decreased risk of anxiety in diabetic patients receiving glucagon-like Peptide-1 receptor agonist: a nationwide, population-based cohort study","volume":"13","author":"Tsai","year":"2022","journal-title":"Front Pharmacol"},{"issue":"19","key":"10.1016\/j.fertnstert.2024.01.018_bib71","first-page":"S0165","volume":"257","author":"Pozzi","year":"2019","journal-title":"J Affect Disord"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib72","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12902-022-01208-y","article-title":"Lifestyle management in polycystic ovary syndrome - beyond diet and physical activity","volume":"23","author":"Cowan","year":"2023","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib73","doi-asserted-by":"crossref","first-page":"7596","DOI":"10.21037\/apm-21-1212","article-title":"Mindfulness-based therapy versus cognitive behavioral therapy for people with anxiety symptoms: a systematic review and meta-analysis of random controlled trials","volume":"10","author":"Li","year":"2021","journal-title":"Ann Palliat Med"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib74","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.xfnr.2021.11.004","article-title":"Psychosocial interventions for women with polycystic ovary syndrome: a systematic review of randomized controlled trials","volume":"3","author":"Phimphasone-Brady","year":"2022","journal-title":"F&S Reviews"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib75","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1186\/s12888-023-04814-9","article-title":"The effect of cognitive behavioral therapy on depression and anxiety of women with polycystic ovary syndrome: a randomized controlled trial","volume":"23","author":"Majidzadeh","year":"2023","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib76","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.3390\/cimb45040178","article-title":"Effects of mindfulness-based therapy on clinical symptoms and DNA methylation in patients with polycystic ovary syndrome and high metabolic risk","volume":"45","author":"Dema","year":"2023","journal-title":"Curr Issues Mol Biol"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib77","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jbmt.2021.02.018","article-title":"Effect of yoga on polycystic ovarian syndrome: A systematic review","volume":"27","author":"Thakur","year":"2021","journal-title":"J Bodyw Mov Ther"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib78","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1093\/advances\/nmab141","article-title":"Nutritional supplements and complementary therapies in polycystic ovary syndrome","volume":"13","author":"Alesi","year":"2022","journal-title":"Adv Nutr"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib79","doi-asserted-by":"crossref","first-page":"112","DOI":"10.4103\/0973-6131.98223","article-title":"Effect of holistic yoga program on anxiety symptoms in adolescent girls with polycystic ovarian syndrome: a randomized control trial","volume":"5","author":"Nidhi","year":"2012","journal-title":"Int J Yoga"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib80","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.biopsych.2012.11.020","article-title":"The prevalence and correlates of binge eating disorder in the World Health Organization World Mental Health Surveys","volume":"73","author":"Kessler","year":"2013","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib81","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s40519-018-0533-y","article-title":"Increased odds of disordered eating in polycystic ovary syndrome: a systematic review and meta-analysis","volume":"24","author":"Lee","year":"2019","journal-title":"Eat Weight Disord"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib82","doi-asserted-by":"crossref","first-page":"57","DOI":"10.31083\/j.ceog4903057","article-title":"Health-related quality of life and binge eating among adolescent girls with PCOS","volume":"49","author":"Lidaka","year":"2022","journal-title":"Clin Exp Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib83","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ypmed.2009.04.011","article-title":"The effect of eating behavior on weight loss and maintenance during a lifestyle intervention","volume":"49","author":"Ker\u00e4nen","year":"2009","journal-title":"Prev Med"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib84","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.eatbeh.2015.05.009","article-title":"Lifestyle intervention has a beneficial effect on eating behavior and long-term weight loss in obese adults","volume":"18","author":"Nurkkala","year":"2015","journal-title":"Eat Behav"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib85","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.appet.2014.12.226","article-title":"Are common measures of dietary restraint and disinhibited eating reliable and valid in obese persons?","volume":"87","author":"Bohrer","year":"2015","journal-title":"Appetite"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib86","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/s12902-021-00890-8","article-title":"Providing lifestyle advice to women with PCOS: an overview of practical issues affecting success","volume":"21","author":"Ee","year":"2021","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib87","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/osp4.619","article-title":"A pilot randomized controlled trial of liraglutide 3.0 mg for binge eating disorder","volume":"9","author":"Allison","year":"2023","journal-title":"Obes Sci Pract"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib88","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.dsx.2020.03.009","article-title":"Dulaglutide reduces binge episodes in type 2 diabetic patients with binge eating disorder: a pilot study","volume":"14","author":"Da Porto","year":"2020","journal-title":"Diabetes Metab Syndr"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib89","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.mehy.2017.12.029","article-title":"Would glucagon-like peptide-1 receptor agonists have efficacy in binge eating disorder and bulimia nervosa? A review of the current literature","volume":"111","author":"McElroy","year":"2018","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib90","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3109\/07435800.2014.966385","article-title":"Short-term intervention with liraglutide improved eating behavior in obese women with polycystic ovary syndrome","volume":"40","author":"Jensterle","year":"2015","journal-title":"Endocr Res"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib91","doi-asserted-by":"crossref","DOI":"10.1016\/j.yfrne.2022.101039","article-title":"Combined oral contraceptive use and risk for binge eating in women: potential gene \u00d7 hormone interactions","volume":"67","author":"Klump","year":"2022","journal-title":"Front Neuroendocrinol"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib92","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2022.104857","article-title":"Treatment of eating disorders: A systematic meta-review of meta-analyses and network meta-analyses","volume":"142","author":"Monteleone","year":"2022","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib93","unstructured":"National guideline A. In: Eating Disorders: Recognition and Treatment. National Institute for Health and Care Excellence [guidelines]. London: National Institute for Health and Care Excellence (NICE)."},{"key":"10.1016\/j.fertnstert.2024.01.018_bib94","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0233876","article-title":"Long-term effects of a three-component lifestyle intervention on emotional well-being in women with polycystic ovary syndrome (PCOS): a secondary analysis of a randomized controlled trial","volume":"15","author":"Jiskoot","year":"2020","journal-title":"PLOS ONE"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib95","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/oby.2002.5","article-title":"Body image partially mediates the relationship between obesity and psychological distress","volume":"10","author":"Friedman","year":"2002","journal-title":"Obes Res"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib96","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1093\/ejendo\/lvad110","article-title":"Body image concerns in women with polycystic ovary syndrome: a systematic review and meta-analysis","volume":"189","author":"Davitadze","year":"2023","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib97","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.pedn.2023.05.009","article-title":"Polycystic ovary syndrome and body image concerns during adolescence","volume":"72","author":"Saei Ghare Naz","year":"2023","journal-title":"J Pediatr Nurs"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib98","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.jpag.2020.08.018","article-title":"Body perception, self-esteem, and comorbid psychiatric disorders in adolescents diagnosed with polycystic ovary syndrome","volume":"33","author":"Sari","year":"2020","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib99","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jpag.2019.07.008","article-title":"Psychiatric disorders, self-esteem, and quality of life in adolescents with polycystic ovary syndrome","volume":"32","author":"\u00c7oban","year":"2019","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib100","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jpag.2013.08.003","article-title":"Body satisfaction and eating attitudes among girls and young women with and without polycystic ovary syndrome","volume":"27","author":"Karacan","year":"2014","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib101","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1080\/09513590.2022.2118708","article-title":"Depression, anxiety, body image scores, and sexual dysfunction in patients with polycystic ovary syndrome according to phenotypes","volume":"38","author":"\u00c7etinkaya Altunta\u015f","year":"2022","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib102","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.fertnstert.2019.03.027","article-title":"Increased prevalence of eating disorders, low self-esteem, and psychological distress in women with polycystic ovary syndrome: a community-based cohort study","volume":"112","author":"Tay","year":"2019","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib103","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jpsychores.2011.02.005","article-title":"Depression symptoms and body dissatisfaction association among polycystic ovary syndrome women","volume":"71","author":"Pastore","year":"2011","journal-title":"J Psychosom Res"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib104","first-page":"829","article-title":"Body image satisfaction and self-esteem status among the patients with polycystic ovary syndrome","volume":"11","author":"Bazarganipour","year":"2013","journal-title":"Iran J Reprod Med"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib105","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1080\/09513590802288226","article-title":"Exercise and body image distress in overweight and obese women with polycystic ovary syndrome: a pilot investigation","volume":"24","author":"Liao","year":"2008","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib106","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.jaac.2015.08.011","article-title":"A pilot randomized controlled trial of cognitive-behavioral therapy for adolescents with body dysmorphic disorder","volume":"54","author":"Mataix-Cols","year":"2015","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib107","unstructured":"National Collaborating Centre for Mental H. Obsessive-compulsive disorder: core interventions in the treatment of obsessive-compulsive disorder and body dysmorphic disorder. In: National Institute for Health and Care Excellence [guidelines]. Leicester, UK: British Psychological Society. UK."},{"key":"10.1016\/j.fertnstert.2024.01.018_bib108","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.cpr.2016.05.007","article-title":"Cognitive-behavioral therapy for body dysmorphic disorder: A systematic review and meta-analysis of randomized controlled trials","volume":"48","author":"Harrison","year":"2016","journal-title":"Clin Psychol Rev"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib109","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0139177","article-title":"A meta-analytic review of stand-alone interventions to improve body image","volume":"10","author":"Alleva","year":"2015","journal-title":"PLOS ONE"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib110","first-page":"243","article-title":"The effectiveness of counseling based on acceptance and commitment therapy on body image and self-esteem in polycystic ovary syndrome: an RCT","volume":"18","author":"Moradi","year":"2020","journal-title":"Int J Reprod Biomed"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib111","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/eb-2017-102702","article-title":"Recent advances in understanding and managing body dysmorphic disorder","volume":"20","author":"Krebs","year":"2017","journal-title":"Evid Based Ment Health"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib112","first-page":"1976","article-title":"Development of a health-related quality-of-life questionnaire (PCOSQ) for women with polycystic ovary syndrome (PCOS)","volume":"83","author":"Cronin","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib113","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1007\/s11136-016-1232-7","article-title":"Health-related quality of life questionnaire for polycystic ovary syndrome (PCOSQ-50): development and psychometric properties","volume":"25","author":"Nasiri-Amiri","year":"2016","journal-title":"Qual Life Res"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib114","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1210\/clinem\/dgz256","article-title":"Population-based data at ages 31 and 46 show decreased HRQoL and life satisfaction in women with PCOS symptoms","volume":"105","author":"Karjula","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib115","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1111\/jsm.12405","article-title":"Health-related quality of life in patients with polycystic ovary syndrome (PCOS): a model-based study of predictive factors","volume":"11","author":"Bazarganipour","year":"2014","journal-title":"J Sex Med"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib116","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2022.962083","article-title":"Body mass index and quality of life in individuals with polycystic ovary syndrome: dysmorphic concerns and eating disorders as mediators","volume":"10","author":"Barberis","year":"2022","journal-title":"Front Public Health"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib117","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1111\/jpc.15097","article-title":"Quality of life in adolescent girls with polycystic ovary syndrome","volume":"56","author":"Wilson","year":"2020","journal-title":"J Paediatr Child Health"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib118","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.jpag.2016.05.006","article-title":"Health-related quality of life in adolescents and young adults with polycystic ovary syndrome: a systematic review","volume":"29","author":"Kaczmarek","year":"2016","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib119","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1297\/cpe.2022-0010","article-title":"Hyperandrogenism correlates with psychological symptoms in adolescents with polycystic ovary syndrome","volume":"31","author":"Donbalo\u011flu","year":"2022","journal-title":"Clin Pediatr Endocrinol"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib120","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/1477-7525-8-149","article-title":"Do South Asian women with PCOS have poorer health-related quality of life than Caucasian women with PCOS? A comparative cross-sectional study","volume":"8","author":"Jones","year":"2010","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib121","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1186\/s12905-023-02682-9","article-title":"The effects of weight loss on health-related quality of life in obese women with PCOS and controls","volume":"23","author":"Shishehgar","year":"2023","journal-title":"BMC Womens Health"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib122","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/1552-6909.12739","article-title":"Quality of life and body mass index in overweight adult women with polycystic ovary syndrome during a lifestyle modification program","volume":"44","author":"De Fr\u00e8ne","year":"2015","journal-title":"J Obstet Gynecol Neonatal Nurs"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib123","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/cen.14913","article-title":"Combined oral contraceptive pill compared with no medical treatment in the management of polycystic ovary syndrome: A systematic review","volume":"99","author":"Forslund","year":"2023","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib124","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1080\/09513590.2018.1460343","article-title":"Effect of 12-month treatment with metformin and\/or oral contraceptives on health-related quality of life in polycystic ovary syndrome","volume":"34","author":"Altinok","year":"2018","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib125","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s12955-016-0520-9","article-title":"Metformin improved health-related quality of life in ethnic Chinese women with polycystic ovary syndrome","volume":"14","author":"Ou","year":"2016","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib126","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/cen.14931","article-title":"A randomized controlled trial comparing myoinositol with metformin versus metformin monotherapy in polycystic ovary syndrome","volume":"99","author":"Nazirudeen","year":"2023","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib127","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.fertnstert.2009.08.006","article-title":"Improvement in quality-of-life questionnaire measures in obese adolescent females with polycystic ovary syndrome treated with lifestyle changes and oral contraceptives, with or without metformin","volume":"93","author":"Harris-Glocker","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/EJE-20-0066","article-title":"Psychological well-being and personality in relation to weight loss following behavioral modification intervention in obese women with polycystic ovary syndrome: a randomized controlled trial","volume":"183","author":"Oberg","year":"2020","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib129","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1002\/oby.21910","article-title":"Mindfulness-based stress reduction in women with overweight or obesity: A randomized clinical trial","volume":"25","author":"Raja-Khan","year":"2017","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib130","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1080\/0167482X.2018.1502265","article-title":"Effectiveness of cognitive-behavioral therapy (CBT) in improving the quality of life and psychological fatigue in women with polycystic ovarian syndrome: a randomized controlled clinical trial","volume":"40","author":"Abdollahi","year":"2019","journal-title":"J Psychosom Obstet Gynaecol"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib131","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.fertnstert.2018.03.028","article-title":"Cognitive-behavioral therapy improves weight loss and quality of life in women with polycystic ovary syndrome: a pilot randomized clinical trial","volume":"110","author":"Cooney","year":"2018","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib132","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1080\/13548506.2021.2019805","article-title":"The impact of peer-led support groups on health-related quality of life, coping skills and depressive symptomatology for women with PCOS","volume":"28","author":"Ranasinghe","year":"2023","journal-title":"Psychol Health Med"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib133","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3109\/10253890.2014.974030","article-title":"Impact of a mindfulness stress management program on stress, anxiety, depression and quality of life in women with polycystic ovary syndrome: a randomized controlled trial","volume":"18","author":"Stefanaki","year":"2015","journal-title":"Stress"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib134","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1237260","article-title":"Acupuncture improves the emotion domain and lipid profiles in women with polycystic ovarian syndrome: a secondary analysis of a randomized clinical trial","volume":"14","author":"Chang","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib135","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1038\/oby.2012.104","article-title":"Sexual functioning and obesity: a review","volume":"20","author":"Kolotkin","year":"2012","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib136","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/j.1743-6109.2012.02649.x","article-title":"Cardiometabolic risk and female sexual health: the Princeton III summary","volume":"9","author":"Miner","year":"2012","journal-title":"J Sex Med"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib137","doi-asserted-by":"crossref","DOI":"10.1080\/09513590.2023.2221736","article-title":"Sexual function in Chinese women with different clinical phenotypes of polycystic ovary syndrome","volume":"39","author":"Tian","year":"2023","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib138","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-24026-7","article-title":"Female sexual function in different phenotypes of polycystic ovarian syndrome: a comparative cross-sectional study","volume":"12","author":"Yarjanli","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib139","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.jsxm.2018.02.008","article-title":"Health-related lifestyle factors and sexual dysfunction: a meta-analysis of population-based research","volume":"15","author":"Allen","year":"2018","journal-title":"J Sex Med"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib140","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.jsxm.2021.04.004","article-title":"Physical activity and female sexual dysfunction: a lot helps, but not too much","volume":"18","author":"Maseroli","year":"2021","journal-title":"J Sex Med"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib141","article-title":"Beneficial effects of Pilates exercise on female sexual dysfunction: a prospective pilot study","volume":"21","author":"Halis","year":"2023","journal-title":"Rev Int Androl"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib142","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1177\/15598276211001330","article-title":"Distinct protocols of physical exercise may improve different aspects of well-being in women with polycystic ovary syndrome","volume":"17","author":"Kogure","year":"2023","journal-title":"Am J Lifestyle Med"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib143","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.fertnstert.2020.08.1396","article-title":"Lifestyle modifications alone or combined with hormonal contraceptives improve sexual dysfunction in women with polycystic ovary syndrome","volume":"115","author":"Steinberg Weiss","year":"2021","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib144","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.jsxm.2019.08.005","article-title":"Hormonal contraception and female sexuality: position statements from the European society of sexual medicine (ESSM)","volume":"16","author":"Both","year":"2019","journal-title":"J Sex Med"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib145","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.4102\/phcfm.v11i1.1955","article-title":"Prevalence of and factors associated with female sexual dysfunction among women using hormonal and non-hormonal contraception at the Aga Khan University Hospital Nairobi","volume":"11","author":"Butt","year":"2019","journal-title":"Afr J Prim Health Care Fam Med"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib146","first-page":"42","article-title":"Sexual functioning and depressive symptoms in women with diabetes and prediabetes receiving metformin therapy: A pilot study","volume":"125","author":"Krysiak","year":"2017","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.fertnstert.2024.01.018_bib147","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1093\/humrep\/del069","article-title":"Metformin treatment of polycystic ovary syndrome improves health-related quality-of-life, emotional distress and sexuality","volume":"21","author":"Hahn","year":"2006","journal-title":"Hum Reprod"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028224000219?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028224000219?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T08:40:59Z","timestamp":1758012059000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028224000219"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":147,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S0015028224000219"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2024.01.018","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of polycystic ovary syndrome must include assessment and treatment of mental health symptoms","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2024.01.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a92024 American Society for Reproductive Medicine, Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}